C. Bramato

发表

Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting.

G. di Perri, A. Calcagno, G. Cenderello, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Tenofovir Plasma Concentrations According to Companion Drugs: a Cross-Sectional Study of HIV-Positive Patients with Normal Renal Function

G. di Perri, A. Calcagno, I. Motta, 2013, Antimicrobial Agents and Chemotherapy.

Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting.

G. di Perri, A. Calcagno, G. Cenderello, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.